Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adalimumab plus Methotrexate in Pediatric Panuveitis
NCT04588818Phase 2Unknown
- Sponsor
- Sun Yat-sen University
- Start
- Feb 2020
- Primary completion
- Dec 2023
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of adalimumab in panuveitis, sponsored by Sun Yat-sen University. Status: unknown.
02
Drugs
03
Conditions
panuveitis
Beyond the preview
Go deeper on NCT04588818.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04588818.